Open Access<p>Decitabine-Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft versus Host Disease</p>
Author(s) -
Qing Ya Wang,
Yuan Li,
Ze Yin Liang,
Yue Yin,
Wei Liu,
Qian Wang,
Yu Dong,
Yu Sun,
Wei Xu,
Han Ren
Publication year - 2019
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s229768
Subject(s) - decitabine , medicine , regimen , cumulative incidence , myelodysplastic syndromes , incidence (geometry) , myeloid leukemia , gastroenterology , transplantation , hematopoietic stem cell transplantation , conditioning regimen , acute leukemia , leukemia , oncology , bone marrow , biology , biochemistry , gene expression , physics , gene , optics , dna methylation
To evaluate the role of Decitabine in the allo-HSCT conditioning regimen for intermediate- and high-risk patients with MDS or AML.